期刊文献+

术前区域性动脉灌注化疗对进展期胃癌预后的影响 被引量:3

Effect of Preoperative Regional Intra-Arterial Infusion Chemo therapy on the Prognosis of Advanced Gastric Cancer
下载PDF
导出
摘要 目的 探讨术前区域性动脉灌注化疗对进展期胃癌预后的影响。方法 对 80例行根治性手术切除的进展期胃癌患者 (其中 3 3例术前行介入化疗 )的临床资料进行分析 ,并应用Cox比例风险模型对可能影响胃癌患者预后的临床病理、治疗措施及分子生物学等 11项指标进行多因素回归分析。结果 术前介入化疗组患者 5年生存率为 59.3 % ,显著高于对照组术后 5年生存率的 47.6% (P<0 .0 5)。Cox多因素回归分析显示 ,术前动脉插管介入化疗为影响进展期胃癌患者术后长期存活的独立预后因素之一。 Objective To evaluate the effect of p reoperative regional intra-arterial infusion chemotherapy on the prognosis of a dvanced gastric cancer. Methods The clinical data of 80 patients who u nderwent curative resection for advanced gastric cancers were summarized.Among t hem,33 patients carried out preoperative regional intra-arterial infusion chemo therapy were as the interventional chemotherapy group,and the remaining 47 patie nts were the control group.Eleven factors including clinical and pathological da ta,treatment procedures and molecular biological makers that contributed to the long-term survival rate were analyzed by Cox multivariate regression analysis.Results The 5-year survival rate of the interv entional group was 59.3%,and the control group 47.6% .There was significant difference between two groups ( P <0.05).Multivariate regression analysis revealed that the p reoperative regional intra-arterial infusion chemotherapy was one of the indepe ndent factors affecting the long-term survival of patients with advanced gastri c cancers.Conclusion The preoperative regional intra-art erial infusion chemotherapy has important value for improving the prognosis of g astric cancer.
出处 《中国普外基础与临床杂志》 CAS 2003年第5期480-481,484,共3页 Chinese Journal of Bases and Clinics In General Surgery
关键词 术前 区域性动脉灌注化疗 进展期胃癌 预后 根治性手术切除 Stomach neoplasm Intra-arte rial chemotherapy Prognosis Cox regression analysis
  • 相关文献

参考文献8

  • 1邹寿椿,裘华森,张成武,施敦,赵大建,姜蔚,张静霞,陶厚权.胃癌围手术期三联序贯疗法的临床研究和随访[J].中华消化杂志,1999,19(3):210-211. 被引量:17
  • 2刘福坤.进展期胃癌手术前后介入治疗[J].中国实用外科杂志,2001,21(7):403-404.
  • 3Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer[J]. Br J Surg, 1997; 84(12):1651.
  • 4Tokairin Y, Maruyama M, Baba H, et al. Pharmacokinetics of"subselective" arterial infusion chemotherapy [J]. Gan To Kagaku Ryoho, 2001; 28(11) : 1795.
  • 5Kosaka T, Ueshige N, Sugaya J, et al. Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer [J]. Gan To Kagaku Ryoho, 1998; 25(9) ; 1288.
  • 6Masuyama M, Taniguchi H, Takeuchi K, et al. Recurrence and survival rate of advanced gastric cancer after preoperative EAP-Ⅱ intra-arterial infusion therapy [J]. Gan To Kagaku Ryoho, 1994;21(13): 2253.
  • 7Bozzetti F,Bonfanti G,Morabito A,et al. A muhifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection [J]. Surg Gynecol Obstet, 1986; 162(3) : 229.
  • 8Hermanek P, Wittekind C. News of TNM and its use for classification of gastric cancer [J]. World J Surg, 1995; 19(4) : 491.

二级参考文献1

  • 1Wu C C,J Am Coll Surg,1997年,184卷,611页

共引文献24

同被引文献24

  • 1刘国庆.胃癌术前动脉化疗对癌细胞凋亡和增殖的影响[J].陕西医学杂志,2004,33(11):1049-1050. 被引量:1
  • 2陈亮,张思河,张青,田蓉.大肠癌靶向治疗临床试验的研究进展[J].中国肿瘤生物治疗杂志,2006,13(3):230-234. 被引量:3
  • 3Zalcberg JR, Siderov J, Simes J. On behalf the Australasian gastrointestinal trials group, the role of 5-Fluorouracil does in the adjavant therapy of colorectal cancer [J]. Ann Oncol, 1996; 7(1)∶41
  • 4Ragnhammar P, Hafstrm L, Nygren P, et al. A systematic overview of chemotherapy effects in colorectal cancer [J]. Acta Oncol, 2001; 40(2-3)∶282
  • 5Ohno S, Sumiyoshi Y, Mori M, et al. Hyperthermia for rectal cancer [J]. Surgery, 2002; 131(1 Suppl)∶S121
  • 6Zalcberg JR, Siderov J, Simes J. On Behalf the Australasian Gastrointestinal Trials Group, the Role of 5-Fluorouracil Does in the Adjavant Therapy of Colorectal Cancer[J]. Ann Oncol, 1996,7(1) :41-42.
  • 7Ragnhammar P, Hafstrom L, Nygren P, et al. A Systematic Overview of Chemotherapy Effects in Colorectal Cancer[J]. Acta Oncol, 2001,40(2-3) : 282-308.
  • 8Ohno S, Sumiyoshi Y, Mori M, et al. Hyperthermia for rectal cancer[J]. Surgery, 2002, 131(1 Suppl): 121-127.
  • 9Hughes BG,Yip D,Chao M,et al.Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophagel adenocarcinoma:an Australian multi centre experience.ANZ J Surg,2004,74:951-956.
  • 10Yeh KH,Cheng AL.Recent advances in therapy for gastric cancer.J Formos Med Assoc,2004,103:171-185.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部